Jean-Jacques Body

5.5k total citations · 1 hit paper
24 papers, 2.8k citations indexed

About

Jean-Jacques Body is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Jean-Jacques Body has authored 24 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 13 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Surgery. Recurrent topics in Jean-Jacques Body's work include Bone health and treatments (21 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Cancer Diagnosis and Treatment (10 papers). Jean-Jacques Body is often cited by papers focused on Bone health and treatments (21 papers), Radiopharmaceutical Chemistry and Applications (13 papers) and Cancer Diagnosis and Treatment (10 papers). Jean-Jacques Body collaborates with scholars based in Belgium, United States and United Kingdom. Jean-Jacques Body's co-authors include Allan Lipton, Michelle Fan, Katia Tonkin, Alison Stopeck, Ada Braun, Guenther G. Steger, Susie Jun, Denise A. Yardley, Yasuhiro Fujiwara and Richard H. De Boer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.

In The Last Decade

Jean-Jacques Body

24 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study

2010 1.1k citations Alison Stopeck, Allan Lipton et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Jean-Jacques Body

Since Specialization

Citations

This map shows the geographic impact of Jean-Jacques Body's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Jacques Body with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Jacques Body more than expected).

Fields of papers citing papers by Jean-Jacques Body

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Jacques Body. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Jacques Body. The network helps show where Jean-Jacques Body may publish in the future.

Co-authorship network of co-authors of Jean-Jacques Body

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Jacques Body. A scholar is included among the top collaborators of Jean-Jacques Body based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Jacques Body. Jean-Jacques Body is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Meeting report of the “Symposium on kidney stones and mineral metabolism: calcium kidney stones in 2017” 2019 ·Journal of Nephrology ·(unknown), Naim M. Maalouf, Emmanuel Letavernier, Isabelle Brochériou, Jean-Jacques Body, Benjamin A. Vervaet, (unknown), (unknown), Romy Gadisseur, (unknown), Frédéric Cotton, Giovanni Gambaro, Michel Daudon, Khashayar Sakhaee	14
2	Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study 2018 ·Journal of bone oncology ·Roger von Moos, Jean-Jacques Body, (unknown), Evangelos Terpos, Yves P. Acklin, Jindřich Fínek, João Pereira, Nikos Maniadakis, Guy Hechmati, Susan Talbot, H.P. Sleeboom	3
3	An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries 2017 ·Supportive Care in Cancer ·Jean-Jacques Body, Francesca Gatta, E De Cock, (unknown), (unknown), Pauline Wimberger, Jeroen Mebis, Marc Peeters, Paolo Pedrazzoli, Augusto Caraceni, (unknown), Guy Hechmati	9
4	Pathologic fracture and healthcare resource utilisation: A retrospective study in eight European countries 2016 ·Journal of bone oncology ·Jean-Jacques Body, Yves P. Acklin, Oliver Günther, Guy Hechmati, João Gonçalves-Pereira, Nikos Maniadakis, Evangelos Terpos, Jindřich Fínek, Roger von Moos, Susan Talbot, H.P. Sleeboom	7
5	Hypocalcaemia in patients with metastatic bone disease treated with denosumab 2015 ·European Journal of Cancer ·Jean-Jacques Body, Henry G. Bone, Richard H. De Boer, Alison Stopeck, Catherine Van Poznak, Ronaldo Damião, Karim Fizazi, David H. Henry, Toni Ibrahim, Allan Lipton, Fred Saad, Neal D. Shore, Toshimi Takano, Adam J. Shaywitz, Huei Wang, Oswaldo L. Bracco, Ada Braun, Paul J. Kostenuik	103
6	Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer 2015 ·Supportive Care in Cancer ·Alison Stopeck, Karim Fizazi, Jean-Jacques Body, Janet E. Brown, Michael A. Carducci, Ingo Diel, Yasuhiro Fujiwara, Miguel Martín, Alexander Paterson, Katia Tonkin, Neal D. Shore, Paul Sieber, (unknown), Lawrence I. Karsh, Denise A. Yardley, Huei Wang, Tapan Maniar, Jorge Arellano, Ada Braun	136
7	Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases 2015 ·Supportive Care in Cancer ·Roger von Moos, Jean-Jacques Body, Blair Egerdie, Alison Stopeck, Janet E. Brown, Lesley Fallowfield, Donald L. Patrick, Charles S. Cleeland, (unknown), (unknown), Gavin Marx, Ying Zhou, Ada Braun, Arun Balakumaran, Yi Qian	65
8	Possible survival benefits from zoledronic acid treatment in patients with bone metastases from solid tumours and poor prognostic features—An exploratory analysis of placebo-controlled trials 2013 ·Journal of bone oncology ·Robert E. Coleman, Allan Lipton, (unknown), Richard J. Cook, Ker‐Ai Lee, Fred Saad, Janet E. Brown, Evangelos Terpos, Pierre Major, Norio Kohno, Matthew Smith, Jean-Jacques Body	29
9	Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid 2013 ·Supportive Care in Cancer ·Roger von Moos, Jean-Jacques Body, Blair Egerdie, Alison Stopeck, Janet E. Brown, (unknown), Lesley Fallowfield, Gavin Marx, Charles S. Cleeland, Donald L. Patrick, (unknown), Yi Qian, Ada Braun, Karen Chung	68
10	Reply to V. Fusco et al 2011 ·Journal of Clinical Oncology ·Alison Stopeck, Allan Lipton, Jean-Jacques Body, Guenther G. Steger, Katia Tonkin, Richard H. De Boer, Mikhail Lichinitser, Yasuhiro Fujiwara, Denise A. Yardley, María Eugenia Ibarrarán Viniegra, Michelle Fan, Qi Jiang, Roger Dansey, Susie Jun, Ada Braun	4
11	Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study breakdown → 2010 ·Journal of Clinical Oncology ·Alison Stopeck, Allan Lipton, Jean-Jacques Body, Guenther G. Steger, Katia Tonkin, Richard H. De Boer, Mikhail Lichinitser, Yasuhiro Fujiwara, Denise A. Yardley, María Eugenia Ibarrarán Viniegra, Michelle Fan, Qi Jiang, Roger Dansey, Susie Jun, Ada Braun	1102
12	Bone loss in patients with breast cancer receiving aromatase inhibitors and associated treatment strategies 2008 ·Cancer Treatment Reviews ·Robert E. Coleman, Jean-Jacques Body, Julie R. Gralow, Allan Lipton	41
13	International society of geriatric oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients 2007 ·European Journal of Cancer ·Jean-Jacques Body, Rob Coleman, Philippe Clézardin, Carla Ripamonti, René Rizzoli, Matti Aapro	55
14	Randomized Active-Controlled Phase II Study of Denosumab Efficacy and Safety in Patients With Breast Cancer-Related Bone Metastases 2007 ·Journal of Clinical Oncology ·Allan Lipton, Guenther G. Steger, Jazmín Meneses Figueroa, (unknown), Philippe Solal‐Céligny, Jean-Jacques Body, Richard de Boer, Rossana Berardi, Pere Gascón, Katia Tonkin, Robert E. Coleman, Alexander Paterson, Mark Peterson, Michelle Fan, (unknown), Susie Jun	293
15	Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference 2006 ·Clinical Cancer Research ·Allan Lipton, James R. Berenson, Jean-Jacques Body, Brendan F. Boyce, Øyvind S. Bruland, Michael A. Carducci, Charles S. Cleeland, Denis R. Clohisy, Robert E. Coleman, Richard J. Cook, Theresa A. Guise, Roger Pearse, Trevor J. Powles, Michael J. Rogers, G. David Roodman, Matthew R. Smith, Larry J. Suva, Robert L. Vessella, Katherine N. Weilbaecher, Laura King	14
16	Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON® automated analyzer 2004 ·Clinical Biochemistry ·Diana L. Ersfeld, D. Sudhaker Rao, Jean-Jacques Body, James L. Sackrison, (unknown), Nayana Parikh, (unknown), (unknown), (unknown), Gordon D. MacFarlane	201
17	Oral ibandronate improves bone pain and preserves quality of life in patients with skeletal metastases due to breast cancer 2004 ·Pain ·Jean-Jacques Body, Ingo Diel, Richard H. Bell, Martin Pecherstorfer, М. Р. Личиницер, A. F Lazarev, Debu Tripathy, B. Bergström	137
18	Review of ibandronate in the treatment of metastatic bone disease: Experience from phase III trials 2004 ·Clinical Therapeutics ·Debu Tripathy, Jean-Jacques Body, (unknown)	17
19	Current and future directions in medical therapy 2000 ·Cancer ·Jean-Jacques Body	46
20	Breast cancer cell response to calcitonin: Modulation by growth-regulating agents 1998 ·European Journal of Pharmacology ·Marc Lacroix, (unknown), Jean-Jacques Body	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact